Global Pharmaceutical Excipients Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Pharmaceutical Excipients Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to Recent Energy Crisis
4.2.5 Cumulative Impact due to Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply & Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Pharmaceutical Excipients Market, By Functionality
5.1 Y-o-Y Growth Comparison, By Functionality
5.2 Global Pharmaceutical Excipients Market Share Analysis, By Functionality
5.3 Global Pharmaceutical Excipients Market Size and Forecast, By Functionality
5.3.1 Binders and Adhesives
5.3.2 Disintegrants
5.3.3 Coating Material
5.3.4 Coloring Agents
5.3.5 Solubilizers
5.3.6 Flavors
5.3.7 Sweetening Agents
5.3.8 Diluents
5.3.9 Lubricants
5.3.10 Buffers
5.3.11 Emulsifying Agents
5.3.12 Preservatives
5.3.13 Antioxidants
5.3.14 Sorbents
5.3.15 Solvents
5.3.16 Emollients
5.3.17 Glidents
5.3.18 Chelating Agents
5.3.19 Antifoaming Agents
5.3.20 Others
6 Global Pharmaceutical Excipients Market, By Dosage Form
6.1 Y-o-Y Growth Comparison, By Dosage Form
6.2 Global Pharmaceutical Excipients Market Share Analysis, By Dosage Form
6.3 Global Pharmaceutical Excipients Market Size and Forecast, By Dosage Form
6.3.1 Solid
6.3.2 Semi-Solid
6.3.3 Liquid
7 Global Pharmaceutical Excipients Market, By Route of Administration
7.1 Y-o-Y Growth Comparison, By Route of Administration
7.2 Global Pharmaceutical Excipients Market Share Analysis, By Route of Administration
7.3 Global Pharmaceutical Excipients Market Size and Forecast, By Route of Administration
7.3.1 Oral Excipients
7.3.2 Topical Excipients
7.3.3 Parenteral Excipients
7.3.4 Other Excipients
8 Global Pharmaceutical Excipients Market, By Distribution Channel
8.1 Y-o-Y Growth Comparison, By Distribution Channel
8.2 Global Pharmaceutical Excipients Market Share Analysis, By Distribution Channel
8.3 Global Pharmaceutical Excipients Market Size and Forecast, By Distribution Channel
8.3.1 Direct Tender
8.3.2 Retail Sales
8.3.3 Others
9 Global Pharmaceutical Excipients Market, By End User
9.1 Y-o-Y Growth Comparison, By End User
9.2 Global Pharmaceutical Excipients Market Share Analysis, By End User
9.3 Global Pharmaceutical Excipients Market Size and Forecast, By End User
9.3.1 Pharmaceutical and Biopharmaceutical Companies
9.3.2 Contract Formulators
9.3.3 Research Organization and Academics
9.3.4 Others
10 Global Pharmaceutical Excipients Market, By Region
10.1 Global Pharmaceutical Excipients Market Share Analysis, By Region
10.2 Global Pharmaceutical Excipients Market Size and Forecast, By Region
10.3 Global Pharmaceutical Excipients Market Trends and Forecast, By Region
11 North America Pharmaceutical Excipients Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 North America Pharmaceutical Excipients Size and Forecast, By Functionality
11.3 North America Pharmaceutical Excipients Size and Forecast, By Dosage Form
11.4 North America Pharmaceutical Excipients Size and Forecast, By Route of Administration
11.5 North America Pharmaceutical Excipients Size and Forecast, By Distribution Channel
11.6 North America Pharmaceutical Excipients Size and Forecast, By End User
11.7 North America Pharmaceutical Excipients Size and Forecast, By Country
11.7.1 U.S.
11.7.1.1 Market Size and Forecast, By Functionality
11.7.1.2 Market Size and Forecast, By Dosage Form
11.7.1.3 Market Size and Forecast, By Route of Administration
11.7.1.4 Market Size and Forecast, By Distribution Channel
11.7.1.5 Market Size and Forecast, By End User
11.7.2 Canada
11.7.2.1 Market Size and Forecast, By Functionality
11.7.2.2 Market Size and Forecast, By Dosage Form
11.7.2.3 Market Size and Forecast, By Route of Administration
11.7.2.4 Market Size and Forecast, By Distribution Channel
11.7.2.5 Market Size and Forecast, By End User
11.7.3 Mexico
11.7.3.1 Market Size and Forecast, By Functionality
11.7.3.2 Market Size and Forecast, By Dosage Form
11.7.3.3 Market Size and Forecast, By Route of Administration
11.7.3.4 Market Size and Forecast, By Distribution Channel
11.7.3.5 Market Size and Forecast, By End User
12 Europe Pharmaceutical Excipients Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Europe Pharmaceutical Excipients Size and Forecast, By Functionality
12.3 Europe Pharmaceutical Excipients Size and Forecast, By Dosage Form
12.4 Europe Pharmaceutical Excipients Size and Forecast, By Route of Administration
12.5 Europe Pharmaceutical Excipients Size and Forecast, By Distribution Channel
12.6 Europe Pharmaceutical Excipients Size and Forecast, By End User
12.7 Europe Pharmaceutical Excipients Size and Forecast, By Country
12.7.1 Germany
12.7.1.1 Market Size and Forecast, By Functionality
12.7.1.2 Market Size and Forecast, By Dosage Form
12.7.1.3 Market Size and Forecast, By Route of Administration
12.7.1.4 Market Size and Forecast, By Distribution Channel
12.7.1.5 Market Size and Forecast, By End User
12.7.2 France
12.7.2.1 Market Size and Forecast, By Functionality
12.7.2.2 Market Size and Forecast, By Dosage Form
12.7.2.3 Market Size and Forecast, By Route of Administration
12.7.2.4 Market Size and Forecast, By Distribution Channel
12.7.2.5 Market Size and Forecast, By End User
12.7.3 UK
12.7.3.1 Market Size and Forecast, By Functionality
12.7.3.2 Market Size and Forecast, By Dosage Form
12.7.3.3 Market Size and Forecast, By Route of Administration
12.7.3.4 Market Size and Forecast, By Distribution Channel
12.7.3.5 Market Size and Forecast, By End User
12.7.4 Russia
12.7.4.1 Market Size and Forecast, By Functionality
12.7.4.2 Market Size and Forecast, By Dosage Form
12.7.4.3 Market Size and Forecast, By Route of Administration
12.7.4.4 Market Size and Forecast, By Distribution Channel
12.7.4.5 Market Size and Forecast, By End User
12.7.5 Italy
12.7.5.1 Market Size and Forecast, By Functionality
12.7.5.2 Market Size and Forecast, By Dosage Form
12.7.5.3 Market Size and Forecast, By Route of Administration
12.7.5.4 Market Size and Forecast, By Distribution Channel
12.7.5.5 Market Size and Forecast, By End User
12.7.6 Spain
12.7.6.1 Market Size and Forecast, By Functionality
12.7.6.2 Market Size and Forecast, By Dosage Form
12.7.6.3 Market Size and Forecast, By Route of Administration
12.7.6.4 Market Size and Forecast, By Distribution Channel
12.7.6.5 Market Size and Forecast, By End User
12.7.7 Rest of Europe
12.7.7.1 Market Size and Forecast, By Functionality
12.7.7.2 Market Size and Forecast, By Dosage Form
12.7.7.3 Market Size and Forecast, By Route of Administration
12.7.7.4 Market Size and Forecast, By Distribution Channel
12.7.7.5 Market Size and Forecast, By End User
13 Asia Pacific Pharmaceutical Excipients Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Asia Pacific Pharmaceutical Excipients Size and Forecast, By Functionality
13.3 Asia Pacific Pharmaceutical Excipients Size and Forecast, By Dosage Form
13.4 Asia Pacific Pharmaceutical Excipients Size and Forecast, By Route of Administration
13.5 Asia Pacific Pharmaceutical Excipients Size and Forecast, By Distribution Channel
13.6 Asia Pacific Pharmaceutical Excipients Size and Forecast, By End User
13.7 Asia Pacific Pharmaceutical Excipients Size and Forecast, By Country
13.7.1 China
13.7.1.1 Market Size and Forecast, By Functionality
13.7.1.2 Market Size and Forecast, By Dosage Form
13.7.1.3 Market Size and Forecast, By Route of Administration
13.7.1.4 Market Size and Forecast, By Distribution Channel
13.7.1.5 Market Size and Forecast, By End User
13.7.2 Japan
13.7.2.1 Market Size and Forecast, By Functionality
13.7.2.2 Market Size and Forecast, By Dosage Form
13.7.2.3 Market Size and Forecast, By Route of Administration
13.7.2.4 Market Size and Forecast, By Distribution Channel
13.7.2.5 Market Size and Forecast, By End User
13.7.3 India
13.7.3.1 Market Size and Forecast, By Functionality
13.7.3.2 Market Size and Forecast, By Dosage Form
13.7.3.3 Market Size and Forecast, By Route of Administration
13.7.3.4 Market Size and Forecast, By Distribution Channel
13.7.3.5 Market Size and Forecast, By End User
13.7.4 South Korea
13.7.4.1 Market Size and Forecast, By Functionality
13.7.4.2 Market Size and Forecast, By Dosage Form
13.7.4.3 Market Size and Forecast, By Route of Administration
13.7.4.4 Market Size and Forecast, By Distribution Channel
13.7.4.5 Market Size and Forecast, By End User
13.7.5 Australia
13.7.5.1 Market Size and Forecast, By Functionality
13.7.5.2 Market Size and Forecast, By Dosage Form
13.7.5.3 Market Size and Forecast, By Route of Administration
13.7.5.4 Market Size and Forecast, By Distribution Channel
13.7.5.5 Market Size and Forecast, By End User
13.7.6 New Zealand
13.7.6.1 Market Size and Forecast, By Functionality
13.7.6.2 Market Size and Forecast, By Dosage Form
13.7.6.3 Market Size and Forecast, By Route of Administration
13.7.6.4 Market Size and Forecast, By Distribution Channel
13.7.6.5 Market Size and Forecast, By End User
13.7.7 Singapore
13.7.7.1 Market Size and Forecast, By Functionality
13.7.7.2 Market Size and Forecast, By Dosage Form
13.7.7.3 Market Size and Forecast, By Route of Administration
13.7.7.4 Market Size and Forecast, By Distribution Channel
13.7.7.5 Market Size and Forecast, By End User
13.7.8 Malaysia
13.7.8.1 Market Size and Forecast, By Functionality
13.7.8.2 Market Size and Forecast, By Dosage Form
13.7.8.3 Market Size and Forecast, By Route of Administration
13.7.8.4 Market Size and Forecast, By Distribution Channel
13.7.8.5 Market Size and Forecast, By End User
13.7.9 Rest of Asia
13.7.9.1 Market Size and Forecast, By Functionality
13.7.9.2 Market Size and Forecast, By Dosage Form
13.7.9.3 Market Size and Forecast, By Route of Administration
13.7.9.4 Market Size and Forecast, By Distribution Channel
13.7.9.5 Market Size and Forecast, By End User
14 Latin America Pharmaceutical Excipients Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Latin America Pharmaceutical Excipients Size and Forecast, By Functionality
14.3 Latin America Pharmaceutical Excipients Size and Forecast, By Dosage Form
14.4 Latin America Pharmaceutical Excipients Size and Forecast, By Route of Administration
14.5 Latin America Pharmaceutical Excipients Size and Forecast, By Distribution Channel
14.6 Latin America Pharmaceutical Excipients Size and Forecast, By End User
14.7 Latin America Pharmaceutical Excipients Size and Forecast, By Country
14.7.1 Brazil
14.7.1.1 Market Size and Forecast, By Functionality
14.7.1.2 Market Size and Forecast, By Dosage Form
14.7.1.3 Market Size and Forecast, By Route of Administration
14.7.1.4 Market Size and Forecast, By Distribution Channel
14.7.1.5 Market Size and Forecast, By End User
14.7.2 Argentina
14.7.2.1 Market Size and Forecast, By Functionality
14.7.2.2 Market Size and Forecast, By Dosage Form
14.7.2.3 Market Size and Forecast, By Route of Administration
14.7.2.4 Market Size and Forecast, By Distribution Channel
14.7.2.5 Market Size and Forecast, By End User
14.7.3 Colombia
14.7.3.1 Market Size and Forecast, By Functionality
14.7.3.2 Market Size and Forecast, By Dosage Form
14.7.3.3 Market Size and Forecast, By Route of Administration
14.7.3.4 Market Size and Forecast, By Distribution Channel
14.7.3.5 Market Size and Forecast, By End User
14.7.4 Peru
14.7.4.1 Market Size and Forecast, By Functionality
14.7.4.2 Market Size and Forecast, By Dosage Form
14.7.4.3 Market Size and Forecast, By Route of Administration
14.7.4.4 Market Size and Forecast, By Distribution Channel
14.7.4.5 Market Size and Forecast, By End User
14.7.5 Chile
14.7.5.1 Market Size and Forecast, By Functionality
14.7.5.2 Market Size and Forecast, By Dosage Form
14.7.5.3 Market Size and Forecast, By Route of Administration
14.7.5.4 Market Size and Forecast, By Distribution Channel
14.7.5.5 Market Size and Forecast, By End User
14.7.6 Venezuela
14.7.6.1 Market Size and Forecast, By Functionality
14.7.6.2 Market Size and Forecast, By Dosage Form
14.7.6.3 Market Size and Forecast, By Route of Administration
14.7.6.4 Market Size and Forecast, By Distribution Channel
14.7.6.5 Market Size and Forecast, By End User
14.7.7 Rest of Latin America
14.7.7.1 Market Size and Forecast, By Functionality
14.7.7.2 Market Size and Forecast, By Dosage Form
14.7.7.3 Market Size and Forecast, By Route of Administration
14.7.7.4 Market Size and Forecast, By Distribution Channel
14.7.7.5 Market Size and Forecast, By End User
15 Middle East Pharmaceutical Excipients Analysis and Forecast (2023-2030)
15.1 Introduction
15.2 Middle East Pharmaceutical Excipients Size and Forecast, By Functionality
15.3 Middle East Pharmaceutical Excipients Size and Forecast, By Dosage Form
15.4 Middle East Pharmaceutical Excipients Size and Forecast, By Route of Administration
15.5 Middle East Pharmaceutical Excipients Size and Forecast, By Distribution Channel
15.6 Middle East Pharmaceutical Excipients Size and Forecast, By End User
15.7 Middle East Pharmaceutical Excipients Size and Forecast, By Country
15.7.1 Saudi Arabia
15.7.1.1 Market Size and Forecast, By Functionality
15.7.1.2 Market Size and Forecast, By Dosage Form
15.7.1.3 Market Size and Forecast, By Route of Administration
15.7.1.4 Market Size and Forecast, By Distribution Channel
15.7.1.5 Market Size and Forecast, By End User
15.7.2 UAE
15.7.2.1 Market Size and Forecast, By Functionality
15.7.2.2 Market Size and Forecast, By Dosage Form
15.7.2.3 Market Size and Forecast, By Route of Administration
15.7.2.4 Market Size and Forecast, By Distribution Channel
15.7.2.5 Market Size and Forecast, By End User
15.7.3 Egypt
15.7.3.1 Market Size and Forecast, By Functionality
15.7.3.2 Market Size and Forecast, By Dosage Form
15.7.3.3 Market Size and Forecast, By Route of Administration
15.7.3.4 Market Size and Forecast, By Distribution Channel
15.7.3.5 Market Size and Forecast, By End User
15.7.4 Kuwait
15.7.4.1 Market Size and Forecast, By Functionality
15.7.4.2 Market Size and Forecast, By Dosage Form
15.7.4.3 Market Size and Forecast, By Route of Administration
15.7.4.4 Market Size and Forecast, By Distribution Channel
15.7.4.5 Market Size and Forecast, By End User
15.7.5 South Africa
15.7.5.1 Market Size and Forecast, By Functionality
15.7.5.2 Market Size and Forecast, By Dosage Form
15.7.5.3 Market Size and Forecast, By Route of Administration
15.7.5.4 Market Size and Forecast, By Distribution Channel
15.7.5.5 Market Size and Forecast, By End User
15.7.6 Rest of Middle East & Africa
15.7.6.1 Market Size and Forecast, By Functionality
15.7.6.2 Market Size and Forecast, By Dosage Form
15.7.6.3 Market Size and Forecast, By Route of Administration
15.7.6.4 Market Size and Forecast, By Distribution Channel
15.7.6.5 Market Size and Forecast, By End User
16 Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17 Company Profiles
17.1 Kerry Group plc
17.1.2 Offerings
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2 DFE Pharma
17.2.1 Overview
17.2.2 Offerings
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3 Cargill, Incorporated
17.3.1 Overview
17.3.2 Offerings
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 Pfanstiehl
17.4.1 Overview
17.4.1 Overview
17.4.2 Offerings
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
17.4.6 Key Strategies
17.5 Colorcon
17.5.1 Overview
17.5.2 Offerings
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 MEGGLE GmbH & Co. KG
17.6.1 Overview
17.6.2 Offerings
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 Roquette Fr?res
17.7.1 Overview
17.7.2 Offerings
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies
17.8 The Lubrizol Corporation
17.8.1 Overview
17.8.2 Offerings
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 BASF SE
17.9.1 Overview
17.9.2 Offerings
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
17.10 Avantor, Inc
17.10.1 Overview
17.10.2 Offerings
17.10.3 Key Financials
17.10.4 Business Segment & Geographic Overview
17.10.5 Key Market Developments
17.10.6 Key Strategies
17.11 BENEO
17.11.1 Overview
17.11.2 Offerings
17.11.3 Key Financials
17.11.4 Business Segment & Geographic Overview
17.11.5 Key Market Developments
17.11.6 Key Strategies
17.12 Chemie Trade
17.12.1 Overview
17.12.2 Offerings
17.12.3 Key Financials
17.12.4 Business Segment & Geographic Overview
17.12.5 Key Market Developments
17.12.6 Key Strategies
Inquiry Before Buying
Request Free Sample
Ask For Discount